生命科学资讯

Crescent forms PD-1xVEGF, ADC pact with Kelun, raises $185M

Nationwide Children’s SLC6A1 gene therapy shows early promise

ARCH, Lilly Asia Ventures return to back US-China startup SciNeuro

Daiichi Sankyo avoids payout in long-running patent dispute with Pfizer’s Seagen

Clinical trials tech startup Paradigm raises $78M, acquires part of Roche’s Flatiron - Endpoints News

Clinical trials tech startup Paradigm raises $78M, acquires part of Roche’s Flatiron

Home care startup Inbound Health shuts down

FDA to name Tracy Beth Høeg, who helped lead Covid-shot investigation, to head CDER

Former FDA commissioners slam Prasad's plan for 'sweeping' vaccine changes

FDA seeks to raise user fees for companies running Phase 1 trials outside the US

FDA says it won't release details of claimed Covid vaccine deaths in 'near term'

With Phase 3 Duchenne success, Capricor plots path forward after FDA rejection

Black Diamond reports mid-stage lung cancer data, continues its hunt for a partner

Orion's €180M milestone payment; Iolyx partners dry eye candidate

Pfizer-allied molecular glue startup Triana collects $120M Series B

Excelsior Sciences raises $95M for small molecule drug discovery, manufacturing

Bristol Myers pushes back Cobenfy readout after trial site 'irregularities'

Updated: Pharvaris’ hereditary angioedema drug gets Phase 3 win

Hospitals challenge 340B rebate pilot program in Maine federal court

Pentagon seeks to add WuXi AppTec to military list: report